Skip to content

Public FDA record

Z-0319-2022: NUVASIVE PRECICE Intramedullary Limb Lengthening (IMLL) and (Short) System: Model Number/Item Number/Prod

Recall record Z-0319-2022 for NuVasive Specialized Orthopedics, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0319-2022
Company in FDA record
NuVasive Specialized Orthopedics, Inc.
FDA classification date
Dec 1, 2021
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The Instructions for Use have been updated to include: (1) Clarification that the device is intended for use only in patients 18 years and older, (2) That patients should weigh 50 lbs. or more while undergoing treatment, and (3) That no more than two devices should be implanted at a time.

Source facts

Action
On 11/01/2021, the firm emailed an "URGENT FIELD SAFETY NOTICE" to customers as a follow-up from it February and April 2021 communications. This notice informs of updates to the U.S. IFU which includes: a. Clarifying that - The PRECICE Intramedullary Limb Lengthening System is intended for limb lengthening, open and closed fracture fixation, pseudoarthrosis, mal-unions, non-unions, or bone transport of long bones in adults. b. Warnings - Patients of the PRECICE Intramedullary Limb Lengthening System should not be implanted with more than two devices at a time, and the patient s weight should be a minimum of 50 lbs. These updates clarify the instructions regarding the target patient population based on the latest scientific evidence. Recommended User Actions: 1)The IFU should be consulted on an ongoing basis before and throughout patient treatment. 2)A Recalling Firm representative will be contacting their office to help with any questions or concerns. 3)Acknowledgement of these changes is critical. Review, complete, sign and return the attached Consignee Confirmation Form in accordance with the directions on the form. 4)Precice IMLL System Devices, for patients currently weighing less than 50 pounds and/or with more than two devices implanted should consult their healthcare team for assessment of their treatment progression and consider removal of nails promptly at the end of treatment. Following this recommended action can minimize the potential for implantation risks while also minimizing the risks associated with repetitive surgical interventions and sub-optimal conversion to alternative therapies mid-treatment. Any questions or assistance, contact at email FSNprecice@nuvasive.com or Sr. Dir, Global Quality (858)336-3421 Updated 04/04/2022 - Expansion of Recall to include Precice Uyte and Precice Freedom devices: An "URGENT FIELD SAFETY NOTICE" was emailed on 12/01/2021, to inform customers of two additional device systems included in this recall
Initiated
2021-10-29
Root cause
Device Design
Distribution
U.S.: AK, AL, AR, AZ, CA, CO, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, Puerto Rico, RI, SC, TN, TX, UT, VA, WA, WI, and WV. O.U.S.: Argentina, Australia, Austria, Belgium, Canada, Colombia, Chile, Cyprus, Denmark, Finland, France, Germany, Greece, Hong Kong, India, Ireland, Israel, Italy, Jordan, Luxemburg, Mexico, Netherlands, New Zealand, Norway, Poland, Portugal, Saudi Arabia, Serbia, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, United Kingdom.
Recall number
Z-0319-2022
Recall status
Open, Classified
CDRH record ID
190240
FDA classified
2021-12-01
Recall event number
89001

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗